United Therapeutics COO to Present at TD Cowen Health Care Conference
Event summary
- Michael Benkowitz, President and COO of United Therapeutics, will present at the TD Cowen 46th Annual Health Care Conference on March 2, 2026.
- The presentation will provide a company overview and update from 2:30 to 3:00 p.m. EST.
- The live webcast will be available on United Therapeutics' investor relations website.
- An archived recording will be accessible for 90 days post-event.
The big picture
United Therapeutics' presentation at the TD Cowen conference comes at a time when biotech firms are under pressure to demonstrate both financial performance and social impact. As a public benefit corporation, the company's dual focus on medical innovation and organ transplant technologies sets it apart, but investors will be watching closely for tangible progress in these areas. The event provides a platform for the company to articulate its strategic vision and address any concerns about its unconventional business model.
What we're watching
- Strategic Updates
- How United Therapeutics' updates on novel pharmaceutical therapies and organ transplant technologies will impact its public benefit corporation (PBC) goals.
- Market Positioning
- Whether the company's unconventional approach and PBC status will continue to differentiate it in the competitive biotech landscape.
- Investor Sentiment
- The pace at which investor interest and market response evolve following the conference presentation.
Related topics